Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
bupropion | neuronal acetylcholine receptor subunit alpha-3 | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Disease Management[MeSHID:D019468] Bipolar Disorder[MeSHID:D001714] Unipolar Depression[MeSHID:D003866] Hypertensive disease[MeSHID:D006973] Disease[MeSHID:D004194] Attention deficit hyperactivity disorder[MeSHID:D001289] Diet therapy[MeSHID:D004035] Weight Gain[MeSHID:D015430] Body Weight[MeSHID:D001835] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Seasonal Affective Disorder[MeSHID:D016574] Cessation of smoking[MeSHID:D016540] Mood (psychological function)[MeSHID:D000339] Obesity[MeSHID:D009765] Off-Label Use[MeSHID:D056687] Overweight[MeSHID:D050177] Dyslipidemias[MeSHID:D050171] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] emotional dependency[MeSHID:D003858] Smoking[MeSHID:D012907] Tobacco smoking behavior[MeSHID:D000073869] |
NA | approved | antagonist |
bupropion | 5-hydroxytryptamine receptor 3a | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Disease Management[MeSHID:D019468] Bipolar Disorder[MeSHID:D001714] Unipolar Depression[MeSHID:D003866] Hypertensive disease[MeSHID:D006973] Disease[MeSHID:D004194] Attention deficit hyperactivity disorder[MeSHID:D001289] Diet therapy[MeSHID:D004035] Weight Gain[MeSHID:D015430] Body Weight[MeSHID:D001835] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Seasonal Affective Disorder[MeSHID:D016574] Cessation of smoking[MeSHID:D016540] Mood (psychological function)[MeSHID:D000339] Obesity[MeSHID:D009765] Off-Label Use[MeSHID:D056687] Overweight[MeSHID:D050177] Dyslipidemias[MeSHID:D050171] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] emotional dependency[MeSHID:D003858] Smoking[MeSHID:D012907] Tobacco smoking behavior[MeSHID:D000073869] |
NA | approved | negative modulator |
bupropion | sodium-dependent noradrenaline transporter | small molecule | NA | drugbank , DGIDB | Major Depressive Disorder[MeSHID:D003865] Disease Management[MeSHID:D019468] Bipolar Disorder[MeSHID:D001714] Unipolar Depression[MeSHID:D003866] Hypertensive disease[MeSHID:D006973] Disease[MeSHID:D004194] Attention deficit hyperactivity disorder[MeSHID:D001289] Diet therapy[MeSHID:D004035] Weight Gain[MeSHID:D015430] Body Weight[MeSHID:D001835] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Seasonal Affective Disorder[MeSHID:D016574] Cessation of smoking[MeSHID:D016540] Mood (psychological function)[MeSHID:D000339] Obesity[MeSHID:D009765] Off-Label Use[MeSHID:D056687] Overweight[MeSHID:D050177] Dyslipidemias[MeSHID:D050171] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] emotional dependency[MeSHID:D003858] Smoking[MeSHID:D012907] Tobacco smoking behavior[MeSHID:D000073869] |
0.69 | approved | inhibitor |
bupropion | norepinephrine transporter | NA | Successful target | TTD , DGIDB | Major Depressive Disorder[MeSHID:D003865] Disease Management[MeSHID:D019468] Bipolar Disorder[MeSHID:D001714] Unipolar Depression[MeSHID:D003866] Hypertensive disease[MeSHID:D006973] Disease[MeSHID:D004194] Attention deficit hyperactivity disorder[MeSHID:D001289] Diet therapy[MeSHID:D004035] Weight Gain[MeSHID:D015430] Body Weight[MeSHID:D001835] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Seasonal Affective Disorder[MeSHID:D016574] Cessation of smoking[MeSHID:D016540] Mood (psychological function)[MeSHID:D000339] Obesity[MeSHID:D009765] Off-Label Use[MeSHID:D056687] Overweight[MeSHID:D050177] Dyslipidemias[MeSHID:D050171] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] emotional dependency[MeSHID:D003858] Smoking[MeSHID:D012907] Tobacco smoking behavior[MeSHID:D000073869] |
0.69 | approved | unknown |
bupropion | norepinephrine transporter | NA | Successful target | TTD , DGIDB | Major Depressive Disorder[MeSHID:D003865] Disease Management[MeSHID:D019468] Bipolar Disorder[MeSHID:D001714] Unipolar Depression[MeSHID:D003866] Hypertensive disease[MeSHID:D006973] Disease[MeSHID:D004194] Attention deficit hyperactivity disorder[MeSHID:D001289] Diet therapy[MeSHID:D004035] Weight Gain[MeSHID:D015430] Body Weight[MeSHID:D001835] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Seasonal Affective Disorder[MeSHID:D016574] Cessation of smoking[MeSHID:D016540] Mood (psychological function)[MeSHID:D000339] Obesity[MeSHID:D009765] Off-Label Use[MeSHID:D056687] Overweight[MeSHID:D050177] Dyslipidemias[MeSHID:D050171] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] emotional dependency[MeSHID:D003858] Smoking[MeSHID:D012907] Tobacco smoking behavior[MeSHID:D000073869] |
0.69 | approved | inhibitor |
bupropion | sodium-dependent dopamine transporter | small molecule | NA | drugbank , DGIDB | Major Depressive Disorder[MeSHID:D003865] Disease Management[MeSHID:D019468] Bipolar Disorder[MeSHID:D001714] Unipolar Depression[MeSHID:D003866] Hypertensive disease[MeSHID:D006973] Disease[MeSHID:D004194] Attention deficit hyperactivity disorder[MeSHID:D001289] Diet therapy[MeSHID:D004035] Weight Gain[MeSHID:D015430] Body Weight[MeSHID:D001835] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Seasonal Affective Disorder[MeSHID:D016574] Cessation of smoking[MeSHID:D016540] Mood (psychological function)[MeSHID:D000339] Obesity[MeSHID:D009765] Off-Label Use[MeSHID:D056687] Overweight[MeSHID:D050177] Dyslipidemias[MeSHID:D050171] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] emotional dependency[MeSHID:D003858] Smoking[MeSHID:D012907] Tobacco smoking behavior[MeSHID:D000073869] |
0.87 | approved | inhibitor |
bupropion | serotonin transporter | NA | Successful target | TTD , DGIDB | Major Depressive Disorder[MeSHID:D003865] Disease Management[MeSHID:D019468] Bipolar Disorder[MeSHID:D001714] Unipolar Depression[MeSHID:D003866] Hypertensive disease[MeSHID:D006973] Disease[MeSHID:D004194] Attention deficit hyperactivity disorder[MeSHID:D001289] Diet therapy[MeSHID:D004035] Weight Gain[MeSHID:D015430] Body Weight[MeSHID:D001835] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Seasonal Affective Disorder[MeSHID:D016574] Cessation of smoking[MeSHID:D016540] Mood (psychological function)[MeSHID:D000339] Obesity[MeSHID:D009765] Off-Label Use[MeSHID:D056687] Overweight[MeSHID:D050177] Dyslipidemias[MeSHID:D050171] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] emotional dependency[MeSHID:D003858] Smoking[MeSHID:D012907] Tobacco smoking behavior[MeSHID:D000073869] |
0.13 | approved | unknown |
click here to return to the previous page |